Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS29P29 refers to *Ribosomal protein S29 pseudogene 29*, a **pseudogene** corresponding to the functional ribosomal protein S29 (RPS29)[5]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or lack of necessary regulatory elements[4][5]. RPS29P29 itself does not encode a functional protein and is not associated with known biological, molecular, or therapeutic roles[5]. It is one of several processed pseudogenes scattered throughout the genome that resemble RPS29[2][5]. - RPS29P29 is not a functional gene product, not a protein, receptor, enzyme, transporter, or direct therapeutic target[4][5]. - Functional and disease-related data as well as drug interactions pertain to the real RPS29 gene, not this pseudogene. - If the intention was to refer to a druggable or disease-relevant ribosomal protein, the correct gene is RPS29 ("Ribosomal protein S29", HGNC:10419), not RPS29P29[1][2][7]. - No direct therapeutic, biomarker, or drug-related roles are associated with RPS29P29[5]. RPS29P29 is a non-functional processed pseudogene, not a protein, receptor, or therapeutic target, and cannot be classified within standard molecular target categories. If you are seeking functional, biological, or therapeutic information on ribosomal protein S29, you should reference the canonical gene RPS29, not the pseudogene RPS29P29[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 29 (RPS29P29).